Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
DE000A2LQ2D0
Wed, 22.05.2024
029 Group SE
FY23 as expected // key holding with favourable developments
Topic: 029 published FY23 figures. As 029 holds only minority stakes and
reports under German HGB (no mark-to-market valuation), it was a non-event.
Yet, its key assets continue to perform well. As 029 had no divestments
during FY23 (Emerald Stay was sold in Feb. 2024), the company ge [ … ]
Wed, 14.02.2024
029 Group SE
Portfolio update // NAV carried by key holding
Topic: While Conscious Good ceased operations, 029 sold one of its
holdings, Emerald Stay for € 1.6m, a multiple of 2.7x on its invested
capital. The group's NAV is now mainly carried by Limestone Capital and
TRIP.
Conscious Good. CG was expected to launch a nootropics-based consumer
product [ … ]
Wed, 14.02.2024
029 Group SE
Portfolio update // NAV carried by key holding
Topic: While Conscious Good ceased operations, 029 sold one of its
holdings, Emerald Stay for € 1.6m, a multiple of 2.7x on its invested
capital. The group's NAV is now mainly carried by Limestone Capital and
TRIP.
Conscious Good. CG was expected to launch a nootropics-based consumer
product [ … ]